Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cancer (With or Without Metastasis): early-phase trial registry
3 of 4 indexed Cancer (With or Without Metastasis) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Cancer (With or Without Metastasis): 4 US clinical trials tracked, 3 recruiting.
Cancer (With or Without Metastasis) is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Tyligand Bioscience (Shanghai) Limited, running 1 of these trials.
Enrollment posture brief
Registry condition cancer-with-or-without-metastasis
OPEN 3 | RECR 75% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Cancer (With or Without Metastasis) lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cancer (With or Without Metastasis) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cancer (With or Without Metastasis) is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
WellSpan-THRIVE Cancer QOL Study
WellSpan Health
NCT07433660
Survivors Uniting for Remote Guided Exercise
Colorado State University
NCT07290309
Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)
HealthPartners Institute
NCT07107607
Phase I Study of TSN084 in Patients With Advanced Malignant Tumors.
Tyligand Bioscience (Shanghai) Limited
NCT05300438
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Cancer (With or Without Metastasis) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cancer (With or Without Metastasis) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cancer (With or Without Metastasis) page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Cancer (With or Without Metastasis) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Tyligand Bioscience (Shanghai) Limited sponsors the most Cancer (With or Without Metastasis) trials on record, review their full trial history before evaluating a specific study. See Tyligand Bioscience (Shanghai) Limited's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cancer (With or Without Metastasis) condition card totals 4 registered trials; most-linked intervention TSN084; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.